Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 6—June 2005
Research

Integrating Escherichia coli Antimicrobial Susceptibility Data from Multiple Surveillance Programs

John M. Stelling*†Comments to Author , Karin Travers*, Ronald N. Jones‡§, Philip J. Turner¶, Thomas F. O'Brien*†, and Stuart B. Levy*§
Author affiliations: *Alliance for the Prudent Use of Antibiotics, Boston, Massachusetts, USA; †Brigham and Women's Hospital, Boston, Massachusetts, USA; ‡The Jones Group, North Liberty, Iowa, USA; §Tufts University, Boston, Massachusetts, USA; ¶AstraZeneca, Macclesfield, Cheshire, United Kingdom

Main Article

Table 1

Countries participating in the MYSTIC and SENTRY programs*

System North America Latin America Northern Europe Southern Europe + South Africa Western Pacific
MYSTIC (24 countries) Canada (14, 97),
United States (18, 816) Argentina (3, 41),
Brazil (3, 75),
Colombia (1, 20),
Mexico (4, 170) Belgium (9, 572),
Czech Republic (1, 90),
Germany (7, 668),
Poland (1, 70),
Russia (1, 7),†
Sweden (3, 153),†
Switzerland (1, 40),†
United Kingdom (8, 294) Bulgaria (1, 10),†
Greece (2, 37),
Israel (1, 96),
Italy (5, 369),
Malta (1, 11),†
Spain (5, 517),
Turkey (9, 529) Australia (1, 46),
Hong Kong (1, 20),†
Thailand (1, 70)†
Total (101 sites, 4,818 isolates) 32 sites,
913 isolates 11 sites,
306 isolates 31 sites,
1,894 isolates 24 sites,
1,569 isolates 3 sites,
136 isolates
SENTRY (34 countries) Canada (8, 1,334),
United States (36, 5,438) Argentina (2, 282),
Brazil (5, 488),
Chile (2, 610),
Colombia (1, 181),
Mexico (3, 166),†
Uruguay (1, 17),†
Venezuela (1, 72) Austria (1, 105),†
Belgium (1, 171),
Germany (6, 440),
Ireland (1, 52),
Netherlands (1, 107),†
Poland (1, 141),
Russia (1, 6),†
Sweden (1, 112),
Switzerland (1, 380),
United Kingdom (1, 260) France (9, 1,086),
Greece (1, 212),
Israel (1, 128),
Italy (4, 431),
Portugal (1, 91),†
South Africa (1, 76),
Spain (3, 1,007),
Turkey (3, 217) Australia (4, 480),
China (3, 62),†
Hong Kong (1, 228),
Japan (3, 93),
Philippines (1, 130),
Singapore (2, 118),
Taiwan (3, 98)
Total (114 sites, 14,819 isolates) 44 sites,
6,772 isolates 15 sites,
1,816 isolates 15 sites,
1,774 isolates 23 sites,
3,248 isolates 17 sites,
1,209 isolates

*The number of participating centers at any point from 1997 to 2001 and number of isolates by country are indicated in parentheses.
†Countries excluded from analyses for insufficient data, as defined in the text.

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external